BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 356 filers reported holding BIONTECH SE in Q4 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $761,132 | -2.5% | 7,006 | -3.2% | 0.00% | 0.0% |
Q2 2023 | $780,766 | -44.1% | 7,234 | -35.5% | 0.00% | -57.1% |
Q1 2023 | $1,397,551 | -31.6% | 11,219 | -17.5% | 0.01% | -36.4% |
Q4 2022 | $2,043,443 | -2.7% | 13,603 | -12.6% | 0.01% | -8.3% |
Q3 2022 | $2,100,000 | -35.8% | 15,568 | -29.1% | 0.01% | -36.8% |
Q2 2022 | $3,273,000 | -43.6% | 21,954 | -35.5% | 0.02% | -34.5% |
Q1 2022 | $5,807,000 | -20.2% | 34,046 | +20.2% | 0.03% | -17.1% |
Q4 2021 | $7,278,000 | +116.5% | 28,332 | +130.1% | 0.04% | +94.4% |
Q3 2021 | $3,361,000 | +5.6% | 12,312 | -13.0% | 0.02% | 0.0% |
Q2 2021 | $3,184,000 | +20.9% | 14,155 | -41.3% | 0.02% | +12.5% |
Q1 2021 | $2,633,000 | +35.2% | 24,118 | +0.9% | 0.02% | +33.3% |
Q4 2020 | $1,948,000 | +25.7% | 23,896 | +6.7% | 0.01% | +9.1% |
Q3 2020 | $1,550,000 | +3.6% | 22,395 | -0.1% | 0.01% | -15.4% |
Q2 2020 | $1,496,000 | – | 22,415 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 148,674 | $22,333,808 | 17.21% |
Quinn Opportunity Partners LLC | 262,071 | $39,368,306 | 4.82% |
Temasek Holdings (Private) Ltd | 4,378,022 | $657,666,465 | 3.84% |
PARUS FINANCE (UK) Ltd | 29,988 | $4,504,797 | 3.06% |
Top Ace Asset Management Ltd | 20,000 | $3,004,400 | 2.21% |
Artia Global Partners LP | 37,108 | $5,574,364 | 2.12% |
Boston Common Asset Management, LLC | 269,803 | $40,530 | 1.94% |
FLOSSBACH VON STORCH AG | 3,282,723 | $493,130,649 | 1.88% |
Redwood Investments, LLC | 87,540 | $13,150,259 | 1.76% |
Baader Bank Aktiengesellschaft | 238,800 | $35,881,130 | 1.74% |